XML 17 R5.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]      
Total revenue $ 40,000 $ 26,544 $ 11,236
Operating expenses:      
Research and development 38,594 25,312 29,191
General and administrative 39,787 29,393 14,302
Restructuring charge 11,764 5,528 0
Intangibles impairment charge 27,764 31,700 0
Change in fair value of contingent consideration (52,000) (56,840) (11,180)
Total operating expenses 65,909 35,093 32,313
Loss from Operations (25,909) (8,549) (21,077)
Interest income 1,854 17 224
Other income (expense), net 296 (77) (99)
Loss Before Taxes (23,759) (8,609) (20,952)
Benefit (provision) from income taxes 3,875 8,273 (1,445)
Net Loss After Taxes (19,884) (336) (22,397)
Deemed Dividend 0 0 (147)
Net loss attributable to common stockholders - basic (19,884) (336) (22,544)
Net loss attributable to common stockholders - diluted $ (19,884) $ (336) $ (22,544)
Net loss per common share - basic (in dollars per share) $ (0.10) $ 0 $ (0.19)
Net loss per common share - diluted (in dollars per share) $ (0.10) $ 0 $ (0.19)
Weighted-average common shares outstanding - basic (in shares) 200,546 182,323 118,221
Weighted-average common shares outstanding for diluted (in shares) 200,546 182,323 118,221
Revenue from Contract with Customer, Product and Service [Extensible Enumeration] License [Member] License [Member] License [Member]